1. Clinical impact of peri-device leaks following percutaneous left atrial appendage occlusion: a systematic review and meta-analysis. (3rd October 2022) Authors: Samaras, A; Papazoglou, A; Balomenakis, C; Bekiaridou, A; Moysidis, D; Patsiou, V; Orfanidis, A; Feidakis, A; Giannakoulas, G; Tzikas, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Digoxin and association with mortality in patients discharged from hospital with atrial fibrillation, with or without heart failure. (24th May 2021) Authors: Mpotis, M; Kartas, A; Samaras, A; Akrivos, E; Vrana, E; Liampas, E; Papazoglou, A; Moysidis, D; Papanastasiou, A; Baroutidou, A; Karvounis, H; Tzikas, A; Giannakoulas, G Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mortality in patients with atrial fibrillation with or without heart failure following hospital discharge. (25th November 2020) Authors: Kartas, A; Samaras, A; Vasdeki, D; Dividis, G; Fotos, G; Paschou, E; Forozidou, E; Tsoukra, P; Kotsi, E; Goulas, I; Karagiannidis, E; Karvounis, H; Tzikas, A; Giannakoulas, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial. (25th November 2020) Authors: Tzikas, A; Samaras, A; Kartas, A; Vasdeki, D; Fotos, G; Dividis, G; Paschou, E; Forozidou, E; Tsoukra, P; Kotsi, E; Goulas, I; Karvounis, H; Giannakoulas, G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P386Factors associated with the prescription practices of non-vitamin K antagonists in non valvular atrial fibrillation in daily clinical practice. (19th March 2018) Authors: Samaras, A; Fotos, G; Dividis, G; Paschou, E; Thomaidou, E; Goulas, J; Vasdeki, D; Forozidou, E; Tsoukra, P; Kotsi, E; Kartas, A; Giannakoulas, G; Karvounis, H; Tzikas, A Journal: Europace Issue: Volume 20(2018)Supplement 1 Page Start: i69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Polypharmacy and major adverse events in atrial fibrillation. (24th May 2021) Authors: Tsagkaris, C; Kartas, A; Samaras, A; Papazoglou, A; Moysidis, D; Vrana, E; Vouloagkas, I; Papanastasiou, A; Kotzampasis, G; Baroutidou, A; Karagiannidis, E; Louka, A-M; Matiashova, L; Tzikas, A; Giannakoulas, G Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation. (14th October 2021) Authors: Samaras, A; Vrana, E; Kartas, A; Rampidis, G; Doundoulakis, I; Fotos, G; Efthimiadis, G; Karvounis, H; Tzikas, A; Giannakoulas, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic significance of diabetes mellitus in patients with atrial fibrillation. (24th May 2021) Authors: Papazoglou, A; Kartas, A; Samaras, A; Vouloagkas, I; Vrana, E; Moysidis, D; Akrivos, E; Kotzampasis, G; Papanastasiou, A; Baroutidou, A; Botis, M; Tsagkaris, C; Karagiannidis, E; Tzikas, A; Giannakoulas, G Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗